Neoantigen-targeted CD8+ T cell responses with PD-1 blockade therapyCristina Puig-Saus, Alena Gros, Barbara Sennino et al.|Nature|2023Cited by 206
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonistGiulia Parisi, Antoni Ribas, Paige Krystofinski et al.|Nature Communications|2020Cited by 97